Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about GPR37: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
GPR37 (Parmethin) is an orphan GPCR highly expressed in the CNS and substrates of parkin. It plays critical roles in Parkinson's disease pathogenesis through the PSAP-GPR37-IL-6 axis in oligodendrocytes, ER stress response, and protein quality control mechanisms.
| Gene Symbol | GPR37 |
| Aliases | Parmethin |
| Chromosome | 7q31.3 |
| Protein Type | Gpcr |
| Target Class | Gpcr |
| Function | GPR37 agonists or modulators would activate the receptor to promote dopaminergic neuron survival and neuroprotection, counteracting the neurodegeneration characteristic of Parkinson's disease. Liga... |
| Mechanism of Action | GPR37 agonists or modulators would activate the receptor to promote dopaminergic neuron survival and neuroprotection, counteracting the neurodegeneration characteristic of Parkinson's disease. Ligands binding to GPR37 would enhance G-protein signaling cascades that support neuronal viability and function. |
| Primary Expression | the central nervous system |
| Druggability | Low (0.30) |
| Clinical Stage | Approved |
| Molecular Weight | 52 kDa |
| Amino Acids | 462 aa |
| Pathways | Apoptosis, Neuroinflammatory, Oxidative Stress |
| UniProt ID | O15354 |
| Ensembl ID | ENSG00000170370 |
| GeneCards | GPR37 |
| Human Protein Atlas | GPR37 |
| Associated Diseases | ALS, ALZHEIMER, Alzheimer's disease, Cancer, INFLAMMATION, Infection |
| Known Drugs/Compounds | Prosaposin, TX14(A) |
| Interactions | IL6, PSAP, SMAD4, CTSD, PD1, PI3K |
| SciDEX Target | View Target Profile (10 clinical trials) |
| SciDEX Hypotheses | Oligodendrocyte Protectin D1 Mimetic for Myelin Re |
| KG Connections | 343 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
GPR37["GPR37"]
GPR37 -->|"activates"| Als["Als"]
GPR37 -->|"activates"| Ms["Ms"]
GPR37 -->|"activates"| Inflammation["Inflammation"]
GPR37 -.protects against.-> Neurodegeneration["Neurodegeneration"]
GPR37 -->|"activates"| Neuroinflammation["Neuroinflammation"]
GPR37 -->|"activates"| Parkinson["Parkinson"]
GPR37 -->|"regulates"| Stroke["Stroke"]
h_f71a9791["h-f71a9791"] -->|"target for"| GPR37
PROSAPOSIN["PROSAPOSIN"] -->|"activates"| GPR37
PSAP["PSAP"] -->|"activates"| GPR37
BANG["BANG"] -->|"activates"| GPR37
GALC["GALC"] -->|"activates"| GPR37
RAC1["RAC1"] -->|"activates"| GPR37
CANCER["CANCER"] -->|"activates"| GPR37
PHAGOCYTOSIS["PHAGOCYTOSIS"] -->|"activates"| GPR37
MICROGLIA["MICROGLIA"] -->|"expressed in"| GPR37| Target | Relation | Type | Str |
|---|---|---|---|
| cell_type | expressed_in | entity | 0.95 |
| Microglia | associated_with | cell_type | 0.90 |
| oligodendrocytes | expressed_in | cell_type | 0.88 |
| IL6 | upregulates | gene | 0.85 |
| pro-inflammatory cytokine production | regulates | process | 0.85 |
| anti-inflammatory cytokine production | regulates | process | 0.85 |
| PROINFLAMMATORY CYTOKINE | regulates | protein | 0.80 |
| ANTIINFLAMMATORY CYTOKINE | regulates | protein | 0.80 |
| Proinflammatory Cytokines | regulates | process | 0.80 |
| neuroinflammation | contributes_to | process | 0.80 |
| stroke | implicated_in | disease | 0.80 |
| demyelinating disorders | implicated_in | disease | 0.80 |
| antiinflammatory cytokines | regulates | pathway | 0.80 |
| oxidative stress response | participates_in | pathway | 0.80 |
| NEUROLOGICAL DISEASES | implicated_in | disease | 0.80 |
| GPR37_receptor | encodes | protein | 0.80 |
| Inflammation | activates | disease | 0.75 |
| phagocytosis | activates | process | 0.70 |
| neuroinflammation | mediates | process | 0.70 |
| macrophages | expressed_in | cell_type | 0.70 |
| unfolded protein response | participates_in | pathway | 0.70 |
| oligodendrocytes | inhibits | cell_type | 0.70 |
| oligodendrocytes | protects_against | cell_type | 0.70 |
| neurons | implicated_in | cell_type | 0.70 |
| Als | activates | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Neurodegeneration | protects_against | disease | 0.65 |
| Neuroinflammation | activates | disease | 0.65 |
| Parkinson | activates | disease | 0.65 |
| Cancer | associated_with | disease | 0.65 |
| Inflammation | therapeutic_target | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Parkinson | associated_with | disease | 0.65 |
| Stroke | associated_with | disease | 0.65 |
| Neurodegeneration | regulates | disease | 0.65 |
| Stroke | regulates | disease | 0.65 |
| Ms | regulates | disease | 0.65 |
| Parkinson | regulates | disease | 0.65 |
| Inflammation | regulates | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| Neurodegeneration | causes | disease | 0.65 |
| Inflammation | causes | disease | 0.65 |
| ALS | inhibits | disease | 0.65 |
| Pain | activates | disease | 0.65 |
| IL6 | regulates | gene | 0.64 |
| IL6 | activates | gene | 0.64 |
| OLIGODENDROCYTES | expressed_in | cell_type | 0.64 |
| PSAP | activates | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| PSAP | binds_to | protein | 0.92 |
| h-f71a9791 | targets_gene | hypothesis | 0.90 |
| Zymosan Injection | upregulates | process | 0.85 |
| h-f71a9791 | targets | hypothesis | 0.80 |
| PROSAPOSIN | binds_to | protein | 0.80 |
| BGLAP | binds | gene | 0.75 |
| PROSAPOSIN | activates | protein | 0.72 |
| PSAP | activates | protein | 0.64 |
| BANG | activates | gene | 0.60 |
| GALC | activates | gene | 0.60 |
| RAC1 | activates | gene | 0.60 |
| cannabidiol | associated_with | compound | 0.60 |
| CANCER | activates | gene | 0.60 |
| PHAGOCYTOSIS | activates | gene | 0.60 |
| MICROGLIA | expressed_in | gene | 0.60 |
| MYELIN | inhibits | gene | 0.60 |
| OLIGODENDROCYTE | inhibits | gene | 0.60 |
| NEURON | activates | gene | 0.60 |
| STROKE | associated_with | gene | 0.60 |
| APOPTOSIS | regulates | gene | 0.60 |
| ASTROCYTES | regulates | gene | 0.60 |
| OXIDATIVE STRESS | regulates | gene | 0.60 |
| STROKE | regulates | gene | 0.60 |
| MICROGLIA | regulates | gene | 0.60 |
| CYTOKINES | associated_with | gene | 0.60 |
| INFLAMMATION | activates | gene | 0.60 |
| PARKINSON | activates | gene | 0.60 |
| CYTOKINES | activates | gene | 0.60 |
| PARKINSON | associated_with | gene | 0.60 |
| INFLAMMATION | causes | gene | 0.60 |
| PARKINSON | regulates | gene | 0.60 |
| NEURODEGENERATION | protects_against | gene | 0.60 |
| PARKINSON'S DISEASE | associated_with | gene | 0.60 |
| NEUROINFLAMMATION | activates | gene | 0.60 |
| AND | activates | gene | 0.60 |
| CANCER | expressed_in | entity | 0.60 |
| IL-6 | causes | gene | 0.60 |
| NEURODEGENERATION | causes | gene | 0.60 |
| NEURODEGENERATION | regulates | gene | 0.60 |
| AND | regulates | gene | 0.60 |
| RNA | regulates | gene | 0.60 |
| CANCER | associated_with | gene | 0.60 |
| MYELIN | regulates | gene | 0.60 |
| C1Q | activates | gene | 0.55 |
| ENDOG | co_discussed | protein | 0.50 |
| PSAP | associated_with | gene | 0.50 |
| PHAGOCYTOSIS | regulates | gene | 0.50 |
| microglia | expressed_in | cell_type | 0.50 |
| Neuroinflammation | causes | process | 0.50 |
| Neurodegeneration | causes | disease | 0.50 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution | 0.447 | neurodegeneration | Neuroinflammation resolution mechanisms |
Scientific analyses that reference this entity
neuroinflammation | 2026-04-13 | 2 hypotheses Top: 0.632
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.552
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Role and regulatory mechanism of GPR37 in neurological diseases. [PMID:40822851] | Liu S, Bai T, Liu X, Zhao W, Li X, Sui Y | Front Cell Neurosci | 2025 | 1 |
| Oligodendrocytes drive neuroinflammation and neurodegeneration in Parkinson's di [PMID:39913287] | Ma Q, Tian JL, Lou Y, Guo R, Ma XR, Wu J | Cell Rep | 2025 | 1 |
| Inflammation and Infection in Pain and the Role of GPR37. [PMID:36430912] | Zhang Q, Bang S, Chandra S, Ji RR | Int J Mol Sci | 2022 | 1 |
| Osteocalcin attenuates oligodendrocyte differentiation and myelination via GPR37 [PMID:34678058] | Qian Z, Li H, Yang H, Yang Q, Lu Z, Wang | Sci Adv | 2021 | 1 |
| GPR37 regulates macrophage phagocytosis and resolution of inflammatory pain. [PMID:30010619] | Bang S, Xie YK, Zhang ZJ, Wang Z, Xu ZZ, | J Clin Invest | 2018 | 1 |
| Exosomes as nanocarriers for brain-targeted delivery of therapeutic nucleic acid [PMID:40533746] | ["Sanadgol N", "Abedi M", "Hashemzaei M" | Journal of nanobiotechnology | 2025 | 0 |
| GPR37 processing in neurodegeneration: a potential marker for Parkinson's Diseas [PMID:39256360] | ["Argerich J", "Garma L", "L\u00f3pez-Ca | NPJ Parkinson's disease | 2024 | 0 |
| Activation of GPR37 in macrophages confers protection against infection-induced [PMID:33731716] | Bang S, Donnelly CR, Luo X, Toro-Moreno | Nature communications | 2021 | 0 |
| Disparities in maternal health services in sub-Saharan Africa. [PMID:29572718] | ["Woldegiorgis M", "Hiller J", "Mekonnen | International journal of publi | 2018 | 0 |
| Mice lacking Gpr37 exhibit decreased expression of the myelin-associated glycopr [PMID:28642167] | ["Smith B", "Giddens M", "Neil J", "Owin | Neuroscience | 2017 | 0 |
| Research Designs for Intervention Research with Small Samples II: Stepped Wedge [PMID:26017633] | ["Fok C", "Henry D", "Allen J"] | Prevention science : the offic | 2015 | 0 |
| Global genomic profiling reveals an extensive p53-regulated autophagy program co [PMID:23651856] | ["Kenzelmann Broz D", "Spano Mello S", " | Genes & development | 2013 | 0 |
| Phylogenetic-based propagation of functional annotations within the Gene Ontolog [PMID:21873635] | ["Gaudet P", "Livstone M", "Lewis S", "T | Briefings in bioinformatics | 2011 | 0 |
| Pael receptor induces death of dopaminergic neurons in the substantia nigra via [PMID:17116640] | ["Kitao Y", "Imai Y", "Ozawa K", "Kataok | Human molecular genetics | 2007 | 0 |
| Suppressive effects of 4-phenylbutyrate on the aggregation of Pael receptors and [PMID:16539653] | ["Kubota K", "Niinuma Y", "Kaneko M", "O | Journal of neurochemistry | 2006 | 0 |
| Pael receptor, endoplasmic reticulum stress, and Parkinson's disease. [PMID:14579121] | Takahashi R, Imai Y | Journal of neurology | 2003 | 0 |
| Neurodegeneration: how does parkin prevent Parkinson's disease? [PMID:12842030] | Cookson MR | Current biology : CB | 2003 | 0 |